机译:临床病理学参数可以预测淋巴结转移在ypt0-2直肠癌癌中吗? CaO / Aro / AiO-94和Cao / Aro / AiO-04第3阶段试验的结果
Department of Radiotherapy and Oncology University of Frankfurt;
Institute of Pathology University of Erlangen;
Department of Radiation Oncology and Radiotherapy University of Erlangen;
Department of General Visceral and Pediatric Surgery University Medical Center G?ttingen;
Department of General Visceral and Pediatric Surgery University Medical Center G?ttingen;
Department of General and Visceral and Pediatric Surgery University of Erlangen;
Department of General and Visceral and Pediatric Surgery University of Dresden;
Department of Radiation Oncology and Radiotherapy University of Erlangen;
Institute of Pathology University Medical Center Leipzig;
Institute of Pathology University Medical Center G?ttingen;
Department of Radiotherapy and Oncology University of Frankfurt;
Department of Radiotherapy and Oncology University of Frankfurt;
Lymph node metastases; Rectal cancer; ypT0-2; Pathologic parameters; Prognosis;
机译:临床病理学参数可以预测淋巴结转移在ypt0-2直肠癌癌中吗? CaO / Aro / AiO-94和Cao / Aro / AiO-04第3阶段试验的结果
机译:直肠癌术前放化疗后淋巴结转移的阶段依赖性频率:CAO / ARO / AIO-94试验结果和广泛病理检查的比较前瞻性评估结果
机译:Neoadjuvant直肠评分作为单独替代的疾病存活中的直肠癌在CaO / Aro / AiO-04随机期III试验中
机译:清算方法分析直肠癌直肠癌的淋巴结转移:在低前切除后J-POUCH施工中使用SIGMOID结肠的理由
机译:在前哨淋巴结阳性的女性乳腺癌患者中预测非前哨淋巴结转移的病理参数和公布的列线图评估。
机译:初次切除与新辅助化学放疗然后切除局部可切除或潜在可切除的胰腺癌而无远处转移。跨学科工作组胃肠道肿瘤(AIOARO和CAO)的多中心前瞻性随机II期研究
机译:局部晚期直肠癌的O-0028术前化疗和5-氟尿嘧啶和草酰戊对5氟尿嘧啶的术后化疗:德国CAO / ARO / AIO-04随机III期临床试验的结果